Latest Episodes
12
Why eConsent Still Isn’t Standard in Clinical Trials—and What Could Change That
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Edwin Cohen, Principal Consultant at C&Flow,...
14
Nothing Remains the Same: Why Measures Have to Evolve
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with RJ Wirth, CEO and Consulting Psychometrician...
11
The Missing Link: Why Study Design Makes or Breaks a Clinical Trial
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Farrell Healion, Founder and Principal Consultant...
3
Are We Sacrificing Good for Perfect in Clinical Outcome Assessment?
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacie Hudgens, Chief Scientific and Strategy...
2
More Than an Aspiration: Building a Patient-Centric Evidence Strategy That Lasts
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Lina Eliasson PhD CPsycho, Founding Partner...
1
Building Fit-for-Purpose PRO Instruments: Focused Modern Measures Over General Instruments
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader & COA SME at TransPerfect Life Sciences, is joined by Katja Rudell, VP...